loadpatents
Patent applications and USPTO patent grants for Mendel; David.The latest application filed is for "techniques for reduction of degradation in channels caused by bias temperature instability".
Patent | Date |
---|---|
Techniques For Reduction Of Degradation In Channels Caused By Bias Temperature Instability App 20220268837 - Leong; Han Hua ;   et al. | 2022-08-25 |
Systems And Methods For Transmitting And Receiving Auxiliary Data App 20220006682 - Mendel; David | 2022-01-06 |
Techniques for signal skew compensation Grant 10,523,224 - Mendel , et al. Dec | 2019-12-31 |
Techniques For Signal Skew Compensation App 20190273504 - Mendel; David ;   et al. | 2019-09-05 |
Techniques for signal skew compensation Grant 10,333,535 - Mendel , et al. | 2019-06-25 |
Techniques for heat spreading in an integrated circuit Grant 10,241,844 - Mendel , et al. | 2019-03-26 |
Techniques For Heat Spreading In An Integrated Circuit App 20180329759 - Mendel; David ;   et al. | 2018-11-15 |
Techniques for generating clock signals using oscillators Grant 9,531,390 - Choi , et al. December 27, 2 | 2016-12-27 |
Apparatus for improved encoding and associated methods Grant 9,490,836 - Mendel , et al. November 8, 2 | 2016-11-08 |
Techniques for alignment of parallel signals Grant 9,240,804 - Wortman , et al. January 19, 2 | 2016-01-19 |
Systems and methods for reducing static and total power consumption in programmable logic device architectures Grant 8,806,249 - Mendel August 12, 2 | 2014-08-12 |
Techniques For Alignment of Parallel Signals App 20140218221 - Wortman; Curt ;   et al. | 2014-08-07 |
Apparatus for Improved Encoding and Associated Methods App 20140119388 - Mendel; David ;   et al. | 2014-05-01 |
Systems and methods for reducing static and total power consumption Grant 8,156,355 - Mendel , et al. April 10, 2 | 2012-04-10 |
Purine Derivatives As Kinase Inhibitors App 20110294792 - Engler; Thomas Albert ;   et al. | 2011-12-01 |
Purine derivatives as kinase inhibitors Grant 8,058,425 - Engler , et al. November 15, 2 | 2011-11-15 |
Purine Derivatives As Kinase Inhibitors App 20110207721 - Engler; Thomas Albert ;   et al. | 2011-08-25 |
Aromatic ether derivatives useful as thrombin inhibitors Grant 7,700,628 - Argade , et al. April 20, 2 | 2010-04-20 |
Antithrombotic diamides Grant 7,666,866 - Franciskovich , et al. February 23, 2 | 2010-02-23 |
Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors Grant 7,666,879 - Barda , et al. February 23, 2 | 2010-02-23 |
Antithrombotic ethers Grant 7,615,568 - Franciskovich , et al. November 10, 2 | 2009-11-10 |
Techniques for automated sweeping of parameters in computer-aided design to achieve optimum performance and resource usage Grant 7,594,208 - Borer , et al. September 22, 2 | 2009-09-22 |
Imidazo[1,2-a]pyridine Compounds As Vegf-r2 Inhibitors App 20090227622 - Barda; David Anthony ;   et al. | 2009-09-10 |
Aromatic Ether Derivatives Useful As Thrombin Inhibitors App 20090227566 - Argade; Ankush Baburao ;   et al. | 2009-09-10 |
Systems And Methods For Reducing Static And Total Power Consumption App 20090138696 - Mendel; David ;   et al. | 2009-05-28 |
Purine Derivatives As Kinase Inhibitors App 20090105229 - Engler; Thomas Albert ;   et al. | 2009-04-23 |
Antithrombotic aromatic ethers Grant 7,511,066 - Franciskovich , et al. March 31, 2 | 2009-03-31 |
Method and apparatus for facilitating an adaptive electronic design automation tool Grant 7,509,618 - Hutton , et al. March 24, 2 | 2009-03-24 |
Antithrombotic Diamides App 20090062271 - Franciskovich; Jeffry Bernard ;   et al. | 2009-03-05 |
Systems and methods for reducing static and total power consumption in a programmable logic device Grant 7,467,314 - Mendel , et al. December 16, 2 | 2008-12-16 |
Systems and methods for reducing static and total power consumption in programmable logic device architectures Grant 7,467,310 - Mendel December 16, 2 | 2008-12-16 |
Substituted heterocyclic carboxamides with antithrombotic activity Grant 7,449,457 - Herron , et al. November 11, 2 | 2008-11-11 |
Antithrombotic Ethers App 20080108594 - Franciskovich; Jeffry Bernard ;   et al. | 2008-05-08 |
Systems and methods for reducing static and total power consumption in programmable logic device architectures Grant 7,287,171 - Mendel , et al. October 23, 2 | 2007-10-23 |
Systems and methods for reducing static and total power consumption in a programmable logic device App 20070101175 - Mendel; David ;   et al. | 2007-05-03 |
Systems and methods for reducing static and total power consumption in a programmable logic device Grant 7,188,266 - Mendel , et al. March 6, 2 | 2007-03-06 |
Techniques for automated sweeping of parameters in computer-aided design to achieve optimum performance and resource usage Grant 7,181,703 - Borer , et al. February 20, 2 | 2007-02-20 |
Antithrombotic aromatic ethers App 20070027185 - Franciskovich; Jeffry Bernard ;   et al. | 2007-02-01 |
Substituted carboxamides Grant 7,163,938 - Herron , et al. January 16, 2 | 2007-01-16 |
Substituted heterocyclic amides Grant 7,160,878 - Herron , et al. January 9, 2 | 2007-01-09 |
Aromatic amides Grant 7,129,245 - Beight , et al. October 31, 2 | 2006-10-31 |
Aromatic amides App 20050282862 - Beight, Douglas Wade ;   et al. | 2005-12-22 |
Purine derivatives as kinase inhibitors App 20050090483 - Engler, Thomas Albert ;   et al. | 2005-04-28 |
Substituted heterocyclic carboxamides with antithrombotic activity App 20040242581 - Herron, David Kent ;   et al. | 2004-12-02 |
Antithrombotic amides Grant 6,780,878 - Beight , et al. August 24, 2 | 2004-08-24 |
Aromatic amides Grant 6,759,414 - Beight , et al. July 6, 2 | 2004-07-06 |
Substituted heterocyclic amides App 20040097491 - Herron, David Kent ;   et al. | 2004-05-20 |
Antithrombotic amides Grant 6,716,839 - Beight , et al. April 6, 2 | 2004-04-06 |
Antithrombotic amides Grant 6,716,855 - Beight , et al. April 6, 2 | 2004-04-06 |
Substituted carboxamides App 20040058959 - Herron, David Kent ;   et al. | 2004-03-25 |
Antithrombotic amides Grant 6,710,057 - Beight , et al. March 23, 2 | 2004-03-23 |
Aromatic amides App 20040029874 - Beight, Douglas Wade ;   et al. | 2004-02-12 |
Heteroroaromatic amides as inhibitor of factor Xa Grant 6,689,780 - Beight , et al. February 10, 2 | 2004-02-10 |
Antithrombotic agents Grant 6,677,369 - Beight , et al. January 13, 2 | 2004-01-13 |
Antithrombotic amides App 20030212069 - Beight, Douglas Wade ;   et al. | 2003-11-13 |
Antithrombotic amides App 20030199505 - Beight, Douglas Wade ;   et al. | 2003-10-23 |
Antithrombotic amides App 20030199504 - Beight, Douglas Wade ;   et al. | 2003-10-23 |
Aromatic amides Grant 6,635,657 - Beight , et al. October 21, 2 | 2003-10-21 |
Antithrombotic agents App 20030195223 - Beight, Douglas Wade ;   et al. | 2003-10-16 |
Antithrombotic amides App 20030191153 - Beight, Douglas Wade ;   et al. | 2003-10-09 |
Antithrombotic amides Grant 6,610,704 - Beight , et al. August 26, 2 | 2003-08-26 |
Antithrombotic agents Grant 6,605,626 - Beight , et al. August 12, 2 | 2003-08-12 |
Antithrombotic agents App 20030078431 - Beight, Douglas Wade ;   et al. | 2003-04-24 |
Antithrombotic agents App 20020173518 - Beight, Douglas Wade ;   et al. | 2002-11-21 |
Antithrombotic agents App 20020120007 - Beight, Douglas Wade ;   et al. | 2002-08-29 |
Antithrombotic agents Grant 6,417,200 - Beight , et al. July 9, 2 | 2002-07-09 |
Antithrombotic agents App 20020072531 - Beight, Douglas Wade ;   et al. | 2002-06-13 |
Antithrombotic agents App 20020049234 - Beight, Douglas Wade ;   et al. | 2002-04-25 |
Antithrombotic agents Grant 6,372,759 - Beight , et al. April 16, 2 | 2002-04-16 |
Antithrombotic agents Grant 6,313,122 - Beight , et al. November 6, 2 | 2001-11-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.